AKT1 and hepatocellular carcinoma: Further that MASM suppressed hepatoma cell proliferation, and the Akt/mTOR/ p70S6K and Akt/GSK3β/β-catenin signaling pathways, offering possible mechanisms for its antitumor activity (Liu et al., 2016).